Modern Threads (India) Ltd Share Price

Overview

Modern Threads (India) Ltd share price is currently ₹53.46, down by - ₹2.84 (5.04%) from its previous closing price of ₹56.30. The share price has gained 9.86% over the past month and gained 9.04% over the past year. The stock's 52-week low and high are ₹34.82 and ₹64.66, respectively. Modern Threads (India) Ltd has a market capitalisation of ₹ 200.00 Cr. The share price was last updated on 26 Aug 2026, 03:29 PM IST.

Modern Threads (India) Ltd

MODTHREAD

₹0.00

- ₹2.84

5.04%

Textile

₹0.00(%)1D

Updated: 26 Aug 2026, 03:29:55 pm IST

Market Data

Open Price

₹55.48

Prev. Close

₹56.30

₹52.60

Day Low

₹58.46

Day High

₹34.82

52 Week Low

₹64.66

52 Week High

TextileTextile - Spinning

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

9.92

Sector PE

32.16

PB Ratio

1.40

Sector PB

2.76

EPS

5.39

Dividend Yield

0.00

Today's Volume

12.707 K

5 Day Avg. Volume

36.687 K

PEG Ratio

-0.11

Market Cap.

₹ 200.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Modern Threads (India) Ltd 👋

Modern Threads (India) Ltd is an India-based company. The Company is engaged in the business of textile manufacturing. The Company's products include Wool Tops, Yarns, Lanolin, Grease, and Wool Noil and Spinning Waste. The Company's products reach approximately 25 countries across the globe including Europe, Latin American, Far eastern, Middle East, and African countries. Its woolen division is located in Pragati Path, Bhilwara, Rajasthan. Its Yam Division is located in Raila, Shahpura, Rajasthan.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →

Palak Jain

20 Aug • 1:05 AM · SEBI-Registered Analyst

!Moderna stock jumps over 85% as cancer vaccine trial boosts investor confidence

MODTHREAD

shares made a considerable jump on Wednesday after the company and Merck announced positive results from their personalised mRNA cancer treatment. The stock went up more than 110% in early trading, putting it on track for its biggest-ever one-day gain. The trial marks a major milestone for Moderna as it looks to expand its business in India. It is also being seen as a breakthrough for mRNA technology, with the study marking the first successful Phase 3 trial of an mRNA-based cancer therapy. ‘For 3-5 years of investment